TCOV
GCVRZ

Trust Company of Vermont’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Trust Company of Vermont’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-400
Closed – – 866
2015
Q3 		$0 Hold
400
– – ﹤0.01% 848
2015
Q2 		$0 Hold
400
– – ﹤0.01% 856
2015
Q1 		$0 Sell
400
-150
-27% -$105 ﹤0.01% 835
2014
Q4 		$0 Buy
550
+150
+38% +$102 ﹤0.01% 851
2014
Q3 		$0 Hold
400
– – ﹤0.01% 829
2014
Q2 		$0 Hold
400
– – ﹤0.01% 770
2014
Q1 		$0 Sell
400
-300
-43% -$112 ﹤0.01% 761
2013
Q4 		$0 Hold
700
– – ﹤0.01% 765
2013
Q3 		$2K Hold
700
– – ﹤0.01% 691
2013
Q2 		$2K Buy
+700
New +$1.23K ﹤0.01% 681

Other funds holding GCVRZ

EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.82% 1-Year Est. Return
SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
NGA
New Generation Advisors Manchester, Massachusetts $45.6M AUM 15.43% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return

Trust Company of Vermont's GCVRZ Position: Q4 2015 in Review

Trust Company of Vermont sold out of Sanofi Contingent Value Rights (GCVRZ) in Q4 2015, closing a stake of 400 shares.

Trust Company of Vermont first reported a position in GCVRZ in Q2 2013 and held it in 10 quarters. The position peaked at $2K in Q3 2013. 114 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2015.

  • Trust Company of Vermont reported no remaining Sanofi Contingent Value Rights position as of Q4 2015 after selling out during the quarter.
  • Trust Company of Vermont sold 400 Sanofi Contingent Value Rights shares in Q4 2015.
  • Trust Company of Vermont first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 10 quarters.
  • Trust Company of Vermont's Sanofi Contingent Value Rights position peaked at $2K in Q3 2013.
  • 114 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2015.

Based on Trust Company of Vermont's 13F filing for Q4 2015, filed 29 Jan 2016.